A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 146,626 shares of ZTS stock, worth $25.9 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
146,626
Previous 141,588 3.56%
Holding current value
$25.9 Million
Previous $24 Million 6.1%
% of portfolio
0.45%
Previous 0.44%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$145.54 - $178.83 $733,230 - $900,945
5,038 Added 3.56%
146,626 $25.4 Million
Q1 2024

Apr 29, 2024

BUY
$165.67 - $199.94 $21.8 Million - $26.3 Million
131,695 Added 1331.19%
141,588 $24 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $791,425 - $1.05 Million
5,226 Added 111.98%
9,893 $1.95 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $145,244 - $167,517
869 Added 22.88%
4,667 $812,000
Q2 2023

Aug 15, 2023

BUY
$160.94 - $186.23 $228,856 - $264,819
1,422 Added 59.85%
3,798 $654,000
Q1 2023

Apr 27, 2023

SELL
$145.48 - $175.02 $26,768 - $32,203
-184 Reduced 7.19%
2,376 $395,000
Q4 2022

Feb 07, 2023

SELL
$131.14 - $157.47 $24,654 - $29,604
-188 Reduced 6.84%
2,560 $375,000
Q3 2022

Oct 28, 2022

SELL
$148.29 - $182.55 $13,790 - $16,977
-93 Reduced 3.27%
2,748 $408,000
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $479,451 - $615,076
-3,074 Reduced 51.97%
2,841 $488,000
Q1 2022

May 04, 2022

BUY
$181.39 - $234.03 $68,202 - $87,995
376 Added 6.79%
5,915 $1.12 Million
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $56,751 - $72,379
-293 Reduced 5.02%
5,539 $1.35 Million
Q3 2021

Nov 02, 2021

SELL
$189.29 - $209.69 $152,946 - $169,429
-808 Reduced 12.17%
5,832 $1.13 Million
Q2 2021

Aug 11, 2021

BUY
$155.9 - $187.99 $689,857 - $831,855
4,425 Added 199.77%
6,640 $1.24 Million
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $7,056 - $8,300
-49 Reduced 2.16%
2,215 $349,000
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $1,256 - $1,394
8 Added 0.35%
2,264 $375,000
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $94,461 - $113,939
-689 Reduced 23.4%
2,256 $373,000
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $38,164 - $48,602
-341 Reduced 10.38%
2,945 $404,000
Q1 2020

May 07, 2020

SELL
$92.66 - $144.94 $63,101 - $98,704
-681 Reduced 17.17%
3,286 $387,000
Q4 2019

Feb 06, 2020

SELL
$116.25 - $133.25 $20,343 - $23,318
-175 Reduced 4.23%
3,967 $525,000
Q3 2019

Nov 05, 2019

BUY
$112.57 - $128.43 $103,451 - $118,027
919 Added 28.51%
4,142 $516,000
Q2 2019

Aug 08, 2019

BUY
$97.98 - $114.28 $5,192 - $6,056
53 Added 1.67%
3,223 $366,000
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $28,546 - $35,234
-350 Reduced 9.94%
3,170 $319,000
Q4 2018

Jan 31, 2019

SELL
$79.28 - $95.27 $1,982 - $2,381
-25 Reduced 0.71%
3,520 $301,000
Q3 2018

Oct 29, 2018

SELL
$83.5 - $93.23 $9,602 - $10,721
-115 Reduced 3.14%
3,545 $325,000
Q2 2018

Jul 19, 2018

SELL
$79.9 - $89.2 $1,997 - $2,230
-25 Reduced 0.68%
3,660 $312,000
Q1 2018

Apr 17, 2018

SELL
$71.51 - $84.69 $6,507 - $7,706
-91 Reduced 2.41%
3,685 $308,000
Q4 2017

Jan 17, 2018

SELL
$63.24 - $72.8 $30,291 - $34,871
-479 Reduced 11.26%
3,776 $272,000
Q3 2017

Oct 24, 2017

BUY
$59.73 - $65.4 $254,151 - $278,277
4,255
4,255 $271,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.